X-linked agammaglobulinemia caused by new mutation in BTK gene: a case report
Language English Country Czech Republic Media print-electronic
Document type Case Reports, Journal Article
PubMed
23549506
DOI
10.5507/bp.2013.011
Knihovny.cz E-resources
- MeSH
- Agammaglobulinemia drug therapy genetics MeSH
- Child MeSH
- Genetic Diseases, X-Linked drug therapy genetics MeSH
- Immunoglobulins, Intravenous therapeutic use MeSH
- Humans MeSH
- Mutation * MeSH
- Agammaglobulinaemia Tyrosine Kinase MeSH
- Protein-Tyrosine Kinases genetics MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- BTK protein, human MeSH Browser
- Immunoglobulins, Intravenous MeSH
- Agammaglobulinaemia Tyrosine Kinase MeSH
- Protein-Tyrosine Kinases MeSH
AIM: Primary immunodeficiencies (PID) are becoming a recognized public health problem worldwide. The most important subgroup of these disorders are the antibody deficiencies. X-linked agammaglobulinaemia was the first described entity of this group and is characterised by early onset of recurrent bacterial infections, profound deficiency of all immunoglobulin isotypes and markedly reduced number of peripheral B-lymphocytes. CASE REPORT: We report the case of a 10-year old boy with X-linked agammaglobulinaemia caused by a previously non-described mutation in BTK gene with typical clinical presentation but delayed diagnosis. Following diagnosis, substitution therapy with intravenous immunoglobulins was started and the clinical status of the patient improved. CONCLUSION: We reported a case of X-linked agammaglobulinaemia with delayed diagnosis despite the typical anamnestic signs for primary humoral immunodeficiency. The disease was caused by a previously non-reported mutation in the BTK gene. Measurement of serum immunoglobulins should be performed in all children with recurrent, complicated respiratory infections as a screening test for humoral immunodeficiencies.
References provided by Crossref.org